Improved quality of life following direct‐acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub‐Saharan Africa (the SHARED study)-Reference-Cited by-同舟云学术

Improved quality of life following direct‐acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub‐Saharan Africa (the SHARED study)

Published:2020-10-04 Issue:1 Volume:28 Page:112-120
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Van Nuil Jennifer Ilo¹^ORCID,Umutesi Grace¹,Shumbusho Fabienne¹,Kateera Frederick¹,Dushimimana Jean de Dieu¹,Muvunyi Claude Mambo²,Musabeyezu Emmanuel²,Mukabatsinda Constance²,Ntirenganya Cyprien²,Kabahizi Jules³,Serumondo Janvier⁴,Makuza Jean Damascene⁴^ORCID,Nsanzimana Sabin⁴,Grant Philip⁵,Gupta Neil¹⁶⁷

Affiliation:

1. Partners in Health Rwinkwavu Rwanda

2. College of Medicine and Health Sciences University of Rwanda Kigali Rwanda

3. Rwanda Military Hospital Kigali Rwanda

4. Rwanda Biomedical Center Kigali Rwanda

5. Stanford University School of Medicine Palo Alto CA USA

6. Department of Global Health and Social Medicine Harvard Medical School Boston MA USA

7. Division of Global Health Equity Brigham and Women’s Hospital Boston MA USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13386

Reference43 articles.

1. World Health Organization.Global Hepatitis Report 2017.2017. doi:ISBN 978‐92‐4‐156545‐5.

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis;Mokdad AA;BMC Med,2014

4. International Agency for Research on Cancer.Estimated age‐standardized incidence rates (World) in 2018 Africa both sexes all ages. Globocan.https://www.iarc.fr/. Published 2018. Accessed October 31 2019

5. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial);JHEP Reports;2023-03

2. Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06

3. Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06